These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 31531445)

  • 1. The application of nanotechnology in enhancing immunotherapy for cancer treatment: current effects and perspective.
    Li Y; Ayala-Orozco C; Rauta PR; Krishnan S
    Nanoscale; 2019 Oct; 11(37):17157-17178. PubMed ID: 31531445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gold nanoparticle mediated cancer immunotherapy.
    Almeida JP; Figueroa ER; Drezek RA
    Nanomedicine; 2014 Apr; 10(3):503-14. PubMed ID: 24103304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential of nanoparticle vaccines as a treatment for cancer.
    Urbanavicius D; Alvarez T; Such GK; Johnston APR; Mintern JD
    Mol Immunol; 2018 Jun; 98():2-7. PubMed ID: 29395251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory nanoparticles activate cytotoxic T cells for enhancement of the effect of cancer immunotherapy.
    Wells K; Liu T; Zhu L; Yang L
    Nanoscale; 2024 Oct; 16(38):17699-17722. PubMed ID: 39257225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The quest for nanoparticle-powered vaccines in cancer immunotherapy.
    Sun Z; Zhao H; Ma L; Shi Y; Ji M; Sun X; Ma D; Zhou W; Huang T; Zhang D
    J Nanobiotechnology; 2024 Feb; 22(1):61. PubMed ID: 38355548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulating barriers of tumor microenvironment through nanocarrier systems for improved cancer immunotherapy: a review of current status and future perspective.
    Lan H; Zhang W; Jin K; Liu Y; Wang Z
    Drug Deliv; 2020 Dec; 27(1):1248-1262. PubMed ID: 32865029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combinatory therapy adopting nanoparticle-based cancer vaccination with immune checkpoint blockade for treatment of post-surgical tumor recurrences.
    Chung CK; Da Silva CG; Kralisch D; Chan A; Ossendorp F; Cruz LJ
    J Control Release; 2018 Sep; 285():56-66. PubMed ID: 30008371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer immunotherapy and nanomedicine.
    Sheng WY; Huang L
    Pharm Res; 2011 Feb; 28(2):200-14. PubMed ID: 20821040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies.
    Klippstein R; Pozo D
    Nanomedicine; 2010 Aug; 6(4):523-9. PubMed ID: 20085824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Trends and Innovative Approaches in Cancer Immunotherapy.
    Kim J; Maharjan R; Park J
    AAPS PharmSciTech; 2024 Jul; 25(6):168. PubMed ID: 39044047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle delivery systems in cancer vaccines.
    Krishnamachari Y; Geary SM; Lemke CD; Salem AK
    Pharm Res; 2011 Feb; 28(2):215-36. PubMed ID: 20721603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node-targeting nanovaccines for cancer immunotherapy.
    Wang Q; Wang Z; Sun X; Jiang Q; Sun B; He Z; Zhang S; Luo C; Sun J
    J Control Release; 2022 Nov; 351():102-122. PubMed ID: 36115556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticle-Based Nanomedicines to Promote Cancer Immunotherapy: Recent Advances and Future Directions.
    Liu J; Zhang R; Xu ZP
    Small; 2019 Aug; 15(32):e1900262. PubMed ID: 30908864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Nanotechnology for the Treatment of Melanoma.
    Cassano R; Cuconato M; Calviello G; Serini S; Trombino S
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33546290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering Nanoparticles toward the Modulation of Emerging Cancer Immunotherapy.
    Wang S; Sun Z; Hou Y
    Adv Healthc Mater; 2021 Mar; 10(5):e2000845. PubMed ID: 32790039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nano-Immune-Engineering Approaches to Advance Cancer Immunotherapy: Lessons from Ultra-pH-Sensitive Nanoparticles.
    Li S; Bennett ZT; Sumer BD; Gao J
    Acc Chem Res; 2020 Nov; 53(11):2546-2557. PubMed ID: 33063517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA Nanotechnology-Mediated Cancer Immunotherapy.
    Lin YX; Wang Y; Blake S; Yu M; Mei L; Wang H; Shi J
    Theranostics; 2020; 10(1):281-299. PubMed ID: 31903120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering nanoparticle strategies for effective cancer immunotherapy.
    Yoon HY; Selvan ST; Yang Y; Kim MJ; Yi DK; Kwon IC; Kim K
    Biomaterials; 2018 Sep; 178():597-607. PubMed ID: 29576282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in Cancer Nanovaccines: Harnessing Nanotechnology for Broadening Cancer Immune Response.
    Wang QT; Liu YX; Wang J; Wang H
    ChemMedChem; 2023 Jul; 18(13):e202200673. PubMed ID: 37088719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotechnology-Based Approaches to Promote Lymph Node Targeted Delivery of Cancer Vaccines.
    He R; Zang J; Zhao Y; Dong H; Li Y
    ACS Biomater Sci Eng; 2022 Feb; 8(2):406-423. PubMed ID: 35005881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.